Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The mitochondrial heme exporter FLVCR1b mediates erythroid differentiation
Deborah Chiabrando, … , Paolo Pinton, Emanuela Tolosano
Deborah Chiabrando, … , Paolo Pinton, Emanuela Tolosano
Published November 26, 2012
Citation Information: J Clin Invest. 2012;122(12):4569-4579. https://doi.org/10.1172/JCI62422.
View: Text | PDF
Research Article

The mitochondrial heme exporter FLVCR1b mediates erythroid differentiation

  • Text
  • PDF
Abstract

Feline leukemia virus subgroup C receptor 1 (FLVCR1) is a cell membrane heme exporter that maintains the balance between heme levels and globin synthesis in erythroid precursors. It was previously shown that Flvcr1-null mice died in utero due to a failure of erythropoiesis. Here, we identify Flvcr1b, a mitochondrial Flvcr1 isoform that promotes heme efflux into the cytoplasm. Flvcr1b overexpression promoted heme synthesis and in vitro erythroid differentiation, whereas silencing of Flvcr1b caused mitochondrial heme accumulation and termination of erythroid differentiation. Furthermore, mice lacking the plasma membrane isoform (Flvcr1a) but expressing Flvcr1b had normal erythropoiesis, but exhibited hemorrhages, edema, and skeletal abnormalities. Thus, FLVCR1b regulates erythropoiesis by controlling mitochondrial heme efflux, whereas FLVCR1a expression is required to prevent hemorrhages and edema. The aberrant expression of Flvcr1 isoforms may play a role in the pathogenesis of disorders characterized by an imbalance between heme and globin synthesis.

Authors

Deborah Chiabrando, Samuele Marro, Sonia Mercurio, Carlotta Giorgi, Sara Petrillo, Francesca Vinchi, Veronica Fiorito, Sharmila Fagoonee, Annalisa Camporeale, Emilia Turco, Giorgio R. Merlo, Lorenzo Silengo, Fiorella Altruda, Paolo Pinton, Emanuela Tolosano

×

Figure 1

Identification of a mitochondrial isoform of Flvcr1.

Options: View larger image (or click on image) Download as PowerPoint
Identification of a mitochondrial isoform of Flvcr1.
 
(A) Schematic rep...
(A) Schematic representation of Flvcr1 genetic locus, Flvcr1a and Flvcr1b transcripts, and the predicted protein structures. The MTS in FLVCR1b is indicated in red; cleavage at position 38 results in a protein with 6 hydrophobic transmembrane domains. See also Supplemental Figure 1. (B) Western blot analysis of total protein extracts of HeLa cells overexpressing FLVCR1a-myc, FLVCR1b-myc, or the control vector. Antibody against myc was used. (C) qRT-PCR analysis of Flvcr1b mRNA levels in mouse tissues and (D) human cell lines. Values represent mean ± SEM. n = 6. (E) Western blot analysis of fractionated protein extracts of HeLa cells overexpressing FLVCR1b-myc showing that FLVCR1b is localized in the mitochondrial enriched fraction. Antibodies against GAPDH (cytosolic marker), HADHA (mitochondrial marker), and myc (to detect FLVCR1b) were used. (F) Immunofluorescence analysis of HeLa cells overexpressing FLVCR1b-myc showing the colocalization between FLVCR1b (detected with an antibody against myc) and HADHA. See also Supplemental Figures 2 and 3. Original magnification, ×63. (G) Endogenous FLVCR1b mitochondrial localization revealed by immunoblot analysis. Homogenate, crude, and pure mitochondrial fraction, respectively, before and after Percoll gradient separation prepared from HeLa cells. 20 μg of proteins were loaded on 15% SDS-polyacrylamide gels. (H) Detection of endogenous FLVCR1b by immunoblotting in HEK293 fractionation. IP3R3 and SigmaR1 were used as markers of MAM, tubulin as a marker of cytosol, and VDAC as a marker of mitochondria. 50 μg of proteins were loaded on 15% SDS-polyacrylamide gels. H, homogenate; MC, crude mitochondria; MP,pure mitochondria; CYT, cytosol.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts